Chinese expert consensus on endoscopic injection sclerotherapy for gastroesophageal varices in patients with portal hypertention induced by liver cirrhosis

doi:10.3877/cma.j.issn.2095-7157.2022.04.001

Abstract

Abstract:

Gastroesophageal variceal bleeding induced by liver cirrhosis and portal hypertension is a critical emergency in daily clinics, endoscopic injection sclerotherapy plays an important role in the treatment of gastroesophageal varices. However, no specific consensus on endoscopic injection sclerotherapy has been published. In 2022, a multidisciplinary team all over the country under the leadership of Endoscopic Diagnosis and Treatment of Esophagogastric Varices Group of Chinese Society of Digestive Endoscopology conducted a comprehensive discussion and proposed the consensus, to serve as a tool for Chinese clinicians to standardize endoscopic injection sclerotherapy treatment for gastroesophageal varices. There are twelve parts in the consensus, with a total of 17 recommendations, including grade of gastroesophageal varices, diagnosis of gastroesophageal varices, etc.

Key words: Liver cirrhosis, Portal hypertension, Gastrointestinal varices, Endoscopic injection sclerotherapy, Guideline

Endoscopic Diagnosis and Treatment of Esophagogastric Varices Group, Chinese Society of Digestive Endoscopology, Beijing 100710, China. Chinese expert consensus on endoscopic injection sclerotherapy for gastroesophageal varices in patients with portal hypertention induced by liver cirrhosis[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2022, 09(04): 181-192.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhwcnjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-7157.2022.04.001

https://zhwcnjdzzz.cma-cmc.com.cn/EN/Y2022/V09/I04/181

References 108

[1]	Bosch J，Iwakiri Y．The portal hypertension syndrome：etiology, classification，relevance，and animal models[J]．Hepatol Int, 2018，12(Suppl 1)：1-10.
[2]	de Franchis R，Baveno VI Faculty.Expanding consensus in portal hypertension：Report of the Baveno VI Consensus Workshop：Stratifying risk and individualizing care for portal hypertension[J]．J Hepatol, 2015, 63(3)：743-52.
[3]	中国门静脉高压诊断与监测研究组(CHESS)，中华医学会消化病学分会微创介入协作组，中国医师协会介入医师分会急诊介入专委会等．中国肝静脉压力梯度临床应用专家共识(2018版)[J]．中华肝脏病杂志，2018，26(11)：801-812.
[4]	中华医学会消化病学分会，中华医学会肝病学分会，中华医学会内镜学分会．肝硬化门静脉高压食管胃静脉曲张出血的防治共识[J]．中华肝脏病杂志，2008，16(8)：564-570.
[5]	中华医学会消化内镜学分会食管胃静脉曲张学组．消化道静脉曲张及出血的内镜诊断和治疗规范试行方案(2009年)[J]．中华消化内镜杂志，2010，27(1)：1-4.
[6]	中华医学会肝病学分会，中华医学会消化病学分会，中华医学会消化内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血防治指南[J/CD]．中华胃肠内镜电子杂志，2015，2(4)：1-21.
[7]	中华医学会外科学分会脾及门静脉高压外科学组．肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2019版)[J]．中华外科杂志，2019，57(12)：885-892.
[8]	Tripathi D，Stanley AJ，Hayes PC，et al.Clinical Services and Standards Committee of the British Society of Gastroenterology. U．K. guidelines on the management of variceal haemorrhage in cirrhotic patients[J]．Gut, 2015，64(11)：1680-1704.
[9]	Garcia-Tsao G，Abraldes JG，Berzigotti A，et al.Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases[J]．Hepatology，2017，65(1)：310-335.
[10]	European Association for the Study of the Liver.EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol, 2018，69(2)：406-460.
[11]	de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII Faculty. Baveno VII-Renewing consensus in portal hypertension[J]．J Hepatol, 2022，76(4)：959-974.
[12]	Henry Z，Patel K，Patton H，et al.AGA Clinical Practice Update on Management of Bleeding Gastric Varices：Expert Review[J]．Clin Gastroenterol Hepatol, 2021，19(6)：1098-1107, e1.
[13]	Sarin SK，Kumar A．Gastric varices：profile, classification, and management[J]. Am J Gastroenterol，1989，84(10)：1244-1249.
[14]	Hwang JH，Shergill AK，Acosta RD，et al.American Society for Gastrointestinal Endoscopy.The role of endoscopy in the management of variceal hemorrhage[J]．Gastrointest Endosc，2014，80(2)：221-227.
[15]	Horsley-Silva JL，Vargas HE.Gastrointestinal endoscopy in the cirrhotic patient[J]．Expert Rev Gastroenterol Hepatol，2015，9(7)：1005- 1013.
[16]	McCarty TR，Afinogenova Y，Njei B．Use of Wireless Capsule Endoscopy for the Diagnosis and Grading of Esophageal Varices in Patients With Portal Hypertension：A Systematic Review and Meta-Analysis[J]．J Clin Gastroenterol, 2017，51(2)：174-182.
[17]	Krok KL，Wagennar RR，Kantsevoy SV，et al.Esophageal capsule endoscopy is not the optimal technique to determine the need for primary prophylaxis in patients with cirrhosis[J]．Arch Med Sci，2016，12(2)：365-371.
[18]	中华医学会消化内镜学分会．中国胶囊内镜临床应用指南[J]．中华消化内镜杂志，2014，31(10)：549-558.
[19]	Cardey J，Le Gall C，Michaud L，et al.Screening of esophageal varices in children using esophageal capsule endoscopy：a multicenter prospective study[J]. Endoscopy, 2019，51(1)：10-17.
[20]	帖广玄，张瑜，左晨燕，等．超声胃镜在食管胃底静脉曲张中的应用进展[J]．临床消化病杂志，2018，30(1)：62-65.
[21]	Hammoud GM，Ibdah JA.Utility of endoscopic ultrasound in patients with portal hypertension[J]．World J Gastroenterol，2014，20(39)：14230- 4236.
[22]	Li Y，Li L，Weng HL，et al.Computed tomography vs liver stiffness measurement and magnetic resonance imaging in evaluating esophageal varices in cirrhotic patients: A systematic review and meta-analysis[J]. World J Gastroenterol, 2020，26(18)：2247-2267.
[23]	Tseng YJ，Zeng XQ，Chen J，et al.Computed tomography in evaluating gastroesophageal varices in patients with portal hypertension: A meta-analysis[J]. Dig Liver Dis, 2016，48(7)：695-702.
[24]	胡海东，张见增.216例肝硬化门静脉高压症患者CT血管成像门静脉侧支血管表现研究[J]．实用肝脏病杂志，2016，19(1)：73-76.
[25]	吴琼，吴兴旺，许建明，等．CT血管造影成像对门脉高压症胃底静脉曲张分流状态的评估价值[J]．世界华人消化杂志，2015，23(14): 2268-2273.
[26]	刘桂勤，华静，沈加林. CT门静脉血管成像预测肝硬化门静脉高压食管胃底静脉曲张破裂出血价值[J]．中华实用诊断与治疗杂志，2015, 29(4)：396-398.
[27]	Zhu H，Shi B，Upadhyaya M，et al.Therapeutic endoscopy of localized gastric varices: pretherapy screening and posttreatment evaluation with MDCT portography[J]．Abdom Imaging，2010，35(1)：15-22.
[28]	李保灿，刘清欣，黄文启，等．一站式完成肝脏磁共振动态增强并血管成像对食管胃静脉曲张的诊断价值[J]．中国基层医药，2013, 20(8)：1159-1161.
[29]	Shin SU，Lee JM，Yu MH，et al.Prediction of esophageal varices in patients with cirrhosis: usefulness of three-dimensional MR elastography with echo-planar imaging technique[J]．Radiology，2014，272(1)：143-153.
[30]	封爽，冯慧芬，徐晶，等. 肝硬度值和血小板计数/脾脏厚径比率对肝硬化食管胃底静脉曲张程度的预测价值[J]. 临床肝胆病杂志，2021，37(12)：2819-2823.
[31]	Sami SS，Harman D，Ragunath K，et al.Non-invasive tests for the detection of oesophageal varices in compensated cirrhosis: systematic review and meta-analysis[J]．United European Gastroenterol J, 2018，6(6): 806-818.
[32]	Butler JR，Eckert GJ，Zyromski NJ，et al.Natural history of pancreatitis-induced splenic vein thrombosis：a systematic review and meta-analysis of its incidence and rate of gastrointestinal bleeding[J]. HPB (Oxford), 2011，13(12)：839-845.
[33]	Chafoord C，Frenckner P．New Surgical Treatment of Varicous Veins of the Oesophagus[J]. Acta Oto-Laryngologica，1939，27(4)：422-429.
[34]	MOERSCH HJ.Treatment of esophageal varices by injection of a sclerosing solution[J]．J Am Med Assoc，1947，135(12)：754-757.
[35]	Johnston GW，Rodgers HW.A review of 15 years′ experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices[J]．Br J Surg，1973，60(10)：797-800.
[36]	程留芳，王志强，蔡逢春，等．食管静脉曲张出血硬化治疗十三年回顾[J]．中华消化杂志，2001，21(11)：658-660.
[37]	Al-Khazraji A，Curry MP.The current knowledge about the therapeutic use of endoscopic sclerotherapy and endoscopic tissue adhesives in variceal bleeding[J]．Expert Rev Gastroenterol Hepatol, 2019，13(9)：893-897.
[38]	黄鹤，伦伟健，梁晓燕，等．不同硬化剂在肝硬化食管静脉曲张破裂出血序贯治疗中的效果分析[J]．四川医学，2015，36(10)：1400-1403.
[39]	陈坛辀，林若阳，韩清锡，等．聚桂醇注射液与鱼肝油酸钠治疗食管静脉曲张的临床比较[J]．中国内镜杂志，2014，20(3)：274-276.
[40]	Bhargava DK，Singh B，Dogra R，et al.Prospective randomized comparison of sodium tetradecyl sulfate and polidocanol as variceal sclerosing agents[J]. Am J Gastroenterol，1992，87(2)：182-186.
[41]	Ravi M，Kate V，Ananthakrishnan N．Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy[J]. Indian J Med Res，2001，113：228-233.
[42]	谭玉勇，乐梅先，刘德良．硬化剂在肝硬化食管静脉曲张破裂出血防治中的优化应用[J/CD]．中华胃肠内镜电子杂志，2020，7(1)：39-42.
[43]	Kaplan JA，Bitner RL，Dripps RD.Hypoxia, hyperdynamic circulation, and the hazards of general anesthesia in patients with hepatic cirrhosis[J]. Anesthesiology, 1971，35(4)：427-431.
[44]	于琳，尚国臣，陈丽娜，等．气管插管与非气管插管静脉复合麻醉在食管胃静脉曲张内镜治疗中的对比分析[J]．世界华人消化杂志，2019, 27(5)：299-304.
[45]	Weil D，Cervoni JP，Fares N，et al.Club Francophone pour l’Etude de l’Hypertension Portale (CFEHTP). Management of gastric varices：a French national survey[J]．Eur J Gastroenterol Hepatol，2016，28(5)：576- 581.
[46]	周刚，王志勇，吴建良，等．透明帽辅助内镜下硬化治疗在食管静脉曲张破裂出血中的应用价值[J]．中国内镜杂志，2015，21(2)：136-140.
[47]	Wang AJ，Zheng XL，Hong JB，et al.Cap-Assisted Endoscopic Sclerotherapy vs Ligation in the Long-Term Management of Medium Esophageal Varices：A Randomized Trial[J]．Clin Transl Gastroenterol, 2020，11(12)：e00285.
[48]	Ma L，Huang X，Lian J，et al.Transparent cap-assisted endoscopic sclerotherapy in esophageal varices: a randomized-controlled trial[J]．Eur J Gastroenterol Hepatol, 2018，30(6)：626-630.
[49]	项艺，吴雯玥，张倩倩，等．可充气球囊压迫辅助下硬化剂注射治疗38例食管-胃底静脉曲张的疗效评价[J]．中华消化杂志，2021, 41(12): 812-816.
[50]	吴善彬，许洪伟，刘慧，等．血管内血管旁联合注射硬化剂治疗食管静脉曲张出血[J]．山东大学学报(医学版)，2014，52(6)：85-89.
[51]	李爽，姜之红，张德发，等．内镜超声预测乙肝后肝硬化患者食管静脉曲张进展的回顾性研究[J]．中华消化内镜杂志，2019，36(3): 198-203.
[52]	de Paulo GA，Ardengh JC，Nakao FS，et al.Treatment of esophageal varices：a randomized controlled trial comparing endoscopic sclerotherapy and EUS-guided sclerotherapy of esophageal collateral veins[J]. Gastrointest Endosc，2006，63(3)：396-402; quiz 463.
[53]	尚瑞莲，孙自勤，贾爱芹，等. 超声内镜引导下硬化剂注射对食管静脉曲张套扎术后残留曲张静脉及穿通支序贯治疗的观察[J]. 解放军医学杂志，2014，39(7)：572-575.
[54]	Kovalak M，Lake J，Mattek N，et al.Endoscopic screening for varices in cirrhotic patients：data from a national endoscopic database[J]. Gastrointest Endosc, 2007, 65(1)：82-88.
[55]	North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices.Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices.A prospective multicenter study[J]. N Engl J Med, 1988，319(15): 983-989.
[56]	Amitrano L，Guardascione MA，Manguso F，et al.The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors[J]．Am J Gastroenterol, 2012，107(12)：1872-1878.
[57]	Kovacs TOG，Jensen DM.Varices：Esophageal，Gastric，and Rectal[J]．Clin Liver Dis, 2019, 23(4)：625-642.
[58]	Piai G，Cipolletta L，Claar M，et al.Prophylactic sclerotherapy of high-risk esophageal varices：results of a multicentric prospective controlled trial[J]．Hepatology，1988，8(6)：1495-1500.
[59]	Svoboda P，Kantorová I，Ochmann J，et al.A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices[J]．Surg Endosc，1999，13(6)：580-584.
[60]	Sauerbruch T，Wotzka R，Köpcke W，et al.Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis [J]．N Engl J Med，1988，319(1)：8-15.
[61]	Veterans Affairs Cooperative Variceal Sclerotherapy Group. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial[J]．N Engl J Med, 1991，324(25)：1779-1784.
[62]	Roccarina D，Best LM，Freeman SC，et al.Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis[J]．Cochrane Database Syst Rev，2021，4(4): CD013121.
[63]	Triantos CK，Goulis J，Patch D，et al.An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye[J]. Endoscopy, 2006，38(8)：797-807.
[64]	Dai C，Liu WX，Jiang M，et al.Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage: a meta-analysis[J]．World J Gastroenterol，2015, 21 (8)：2534-2541.
[65]	Roberts D，Best LM，Freeman SC，et al.Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis[J]．Cochrane Database Syst Rev，2021，4(4): CD013155.
[66]	Huang Y，Zhang W，Xiang H，et al.Treatment Strategies in Emergency Endoscopy for Acute Esophageal Variceal Bleeding (CHESS1905): A Nationwide Cohort Study[J]. Front Med (Lausanne), 2022，9：872881.
[67]	Plaz Torres MC, Best LM, Freeman SC, et al. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis：a network meta-analysis[J]. Cochrane Database Syst Rev, 2021, 3(3)：CD013122.
[68]	Sarin SK，Lahoti D，Saxena SP，et al.Prevalence, classification and natural history of gastric varices：a long-term follow-up study in 568 portal hypertension patients[J]．Hepatology，1992，16(6)：1343-1349.
[69]	Kim T, Shijo H, Kokawa H, et al.Risk factors for hemorrhage from gastric fundal varices[J]．Hepatology，1997，25(2)：307-312.
[70]	张其良，刘应莉，王艳荣，等．聚桂醇改良"三明治"法治疗胃底静脉曲张疗效及安全性的Meta分析[J]．中华消化内镜杂志，2022，39(5)：399-404.
[71]	陈庆法，徐燕，田峰，等．经内镜三明治法联合注射聚桂醇及组织胶治疗胃静脉曲张[J]．山东医学高等专科学校学报，2016，38(6)：436-439.
[72]	吕美光，伍英，陈荣平，等．内镜下高渗葡萄糖联合组织胶注射与聚桂醇联合组织胶对胃底静脉曲张出血的疗效分析[J]．中国医学创新，2021，18(18)：161-164.
[73]	吴开玲．聚桂醇与组织黏合剂的不同联用方法在治疗肝硬化胃静脉曲张出血中的应用[J]．检验医学与临床，2018，15(21)：3307-3310.
[74]	Wells M，Chande N，Adams P，et al.Meta-analysis: vasoactive medications for the management of acute variceal bleeds[J]．Aliment Pharmacol Ther, 2012，35(11)：1267-1278.
[75]	Huaringa-Marcelo J，Huaman MR，Branez-Condorena A，et al. Vasoactive Agents for the Management of Acute Variceal Bleeding: A Systematic Review and Meta-analysis[J]．J Gastrointestin Liver Dis, 2021, 30(1)：110-121.
[76]	中华医学会消化病学分会肝胆疾病学组，中国研究型医院学会肝病专业委员会. 特利加压素在肝硬化并发症临床应用的实践指导(2021版)[J]. 临床肝胆病杂志，2022，38(8)：1733-1738.
[77]	Chavez-Tapia NC，Barrientos-Gutierrez T，Tellez-Avila F，et al. Meta-analysis：antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleedingan updated Cochrane review[J]．Aliment Pharmacol Ther, 2011，34(5)：509-518.
[78]	Lee TH，Huang CT，Lin CC，et al.Similar rebleeding rate in 3-day and 7-day intravenous ceftriaxone prophylaxis for patients with acute variceal bleeding[J]．J Formos Med Assoc, 2016，115(7)：547-552.
[79]	Lee YY，Tee HP，Mahadeva S．Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding[J]．World J Gastroenterol, 2014, 20(7)：1790-1796.
[80]	Low DE，Shoenut JP，Kennedy JK，et al.Infectious complications of endoscopic injection sclerotherapy[J]．Arch Intern Med，1986，146(3): 569 -571.
[81]	Jia Y，Dwivedi A，Elhanafi S，et al.Low risk of bacteremia after endoscopic variceal therapy for esophageal varices: a systematic review and meta-analysis[J]．Endosc Int Open, 2015，3(5)：E409-417.
[82]	Garg PK，Sidhu SS，Bhargava DK.Role of omeprazole in prevention and treatment of postendoscopic variceal sclerotherapy esophageal complications.Double-blind randomized study[J]．Dig Dis Sci，1995，40 (7): 1569-1574.
[83]	Akahoshi T，Kawanaka H，Tomikawa M，et al.Effect of proton pomp inhibitor (PPI：Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS)，a randomized control study (24 hour-pH monitoring) [J]．Fukuoka Igaku Zasshi，2013，104(12)：483-489.
[84]	Lin L，Cui B，Deng Y，et al.The Efficacy of Proton Pump Inhibitor in Cirrhotics with Variceal Bleeding：A Systemic Review and Meta-Analysis [J]．Digestion, 2021，102(2)：117-127.
[85]	Alhumaid S，Al Mutair A，Al Alawi Z，et al.Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients：A systematic review and meta-analysis[J]．Gut Pathog, 2021, 13 (1)：17.
[86]	Ma YJ，Cao ZX，Li Y，et al.Proton pump inhibitor use increases hepatic encephalopathy risk：A systematic review and meta-analysis[J]. World J Gastroenterol, 2019，25(21)：2675-2682.
[87]	Elsebaey MA，Tawfik MA，Ezzat S，et al.Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices：a randomized controlled trial[J]．BMC Gastroenterol, 2019，19(1)：23.
[88]	Choi JY，Jo YW，Lee SS，et al.Outcomes of patients treated with Sengstaken-Blakemore tube for uncontrolled variceal hemorrhage[J]. Korean J Intern Med, 2018，33(4)：696-704.
[89]	Escorsell à，Pavel O，Cárdenas A，et al.Variceal Bleeding Study Group. Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial[J]. Hepatology, 2016，63(6)：1957-1967.
[90]	谭玉勇，李陈婕，刘德良．自膨式金属支架治疗难治性食管静脉曲张出血的研究进展[J]．中华消化内镜杂志，2022，39(5)：414-416.
[91]	Hubmann R，Bodlaj G，Czompo M，et al.The use of self-expanding metal stents to treat acute esophageal variceal bleeding[J]．Endoscopy, 2006，38(9)：896-901.
[92]	McCarty TR，Njei B．Self-expanding metal stents for acute refractory esophageal variceal bleeding：A systematic review and meta-analysis[J]. Dig Endosc, 2016，28(5)：539-547.
[93]	Rodrigues SG，Cárdenas A，Escorsell à，et al.Balloon Tamponade and Esophageal Stenting for Esophageal Variceal Bleeding in Cirrhosis：A Systematic Review and Meta-analysis[J]．Semin Liver Dis，2019，39(2): 178-194.
[94]	中国医师协会介入医师分会．中国门静脉高压经颈静脉肝内门体分流术临床实践指南[J]．中华肝脏病杂志，2019，27(8)：582-593.
[95]	Zhu Y，Wang X，Xi X，et al.Emergency Transjugular Intrahepatic Portosystemic Shunt: an Effective and Safe Treatment for Uncontrolled Variceal Bleeding[J]．J Gastrointest Surg, 2019，23(11)：2193-2200.
[96]	Maimone S，Saffioti F，Filomia R，et al.Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS) [J]．Dig Dis Sci, 2019，64(5)：1335-1345.
[97]	Mohan BP，Chandan S，Khan SR，et al.Self-expanding metal stents versus TIPS in treatment of refractory bleeding esophageal varices: a systematic review and meta-analysis[J]．Endosc Int Open，2020，8(3): E291-E300.
[98]	Orozco H，Mercado MA.The evolution of portal hypertension surgery: lessons from 1000 operations and 50 Years′ experience[J]．Arch Surg, 2000，135(12)：1389-1393; discussion 1394.
[99]	Hashizume M，Tanoue K，Morita M，et al.Laparoscopic gastric devascularization and splenectomy for sclerotherapy-resistant esophagogastric varices with hypersplenism[J]．J Am Coll Surg，1998, 187(3): 263-270.
[100]	Sharma A，Vijayaraghavan P，Lal R，et al.Salvage surgery in variceal bleeding due to portal hypertension[J]．Indian J Gastroenterol，2007，26 (1)：14-17.
[101]	谭玉勇，龚箭，刘德良．肝硬化胃静脉曲张内镜下组织黏合剂注射治疗的并发症及防治策略[J]．世界华人消化杂志，2022，30(17)：775- 782.
[102]	Baillie J，Yudelman P．Complications of endoscopic sclerotherapy of esophageal varices[J]．Endoscopy，1992，24(4)：284-291.
[103]	Rajoriya N，Tripathi D．Historical overview and review of current day treatment in the management of acute variceal haemorrhage[J]. World J Gastroenterol，2014，20 (21)：6481-6494.
[104]	崔美兰，贾彦生，康海燕，等．内镜下聚桂醇硬化洽疗重度食管静脉曲张破裂出血的效果观察[J]．临床肝胆病杂志，2017，33(12)：2321- 2325.
[105]	陈巧玲，韩一梅，朱云清，等．乙氧硬化醇和聚桂醇治疗食管静脉曲张破裂出血疗效及并发症比较[J]．陕西医学杂志，2014，34(3)：349-350.
[106]	曹名波，张炳勇，白阳秋，等．内镜下聚桂醇注射治疗食管静脉曲张的临床应用分析[J]．医药论坛杂志，2015，36(2)：22-26.
[107]	牟海军，徐靖宇，庹必光，等．内镜下注射聚桂醇和美兰混合液在食管静脉曲张硬化治疗术中的应用[J]．中国内镜杂志，2018，24(3)：1-5.
[108]	梁祖兰．透明帽辅助内镜下聚桂醇注射治疗49例食管静脉曲张破裂出血患者的疗效观察[J]. 黑龙江中医药，2019, 48(5)：2.

Please choose a citation manager

Content to export